𝔖 Bobbio Scriptorium
✦   LIBER   ✦

High-dose salvage chemotherapy. Germ-cell tumor treatment results in Germany

✍ Scribed by Oliver Rick; Wolfgang Siegert; Jörg Beyer

Publisher
John Wiley and Sons
Year
1999
Tongue
French
Weight
65 KB
Volume
83
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

During the past 10 years, high-dose chemotherapy (HDCT) has emerged as a feasible and curative treatment option for patients with multiply relapsed and/or refractory germ-cell tumors. Increasing experience and the results from clincial trials have helped to optimize the application of HDCT and to define its role in the salvage concepts for germ-cell tumors.

📜 SIMILAR VOLUMES

High-dose chemotherapy with hematopoieti
High-dose chemotherapy with hematopoietic stem-cell support in germ-cell tumor patient treatment: The French experience
✍ A. Fléchon; P. Biron; J.P. Droz 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 105 KB 👁 2 views

## Germ -cell tumors (GCTs) are very chemosensitive and highly curable cancers. For the small proportion of patients who fail conventional chemotherapy (CT), high-dose CT (HDCT) was introduced in France and elsewhere in 1982-1984. We report here on the French experience with HDCT in GCTs. At the C

High-dose chemotherapy as primary treatm
High-dose chemotherapy as primary treatment for poor-risk germ-cell tumors: The Memorial Sloan-Kettering experience (1988–1999)
✍ Michael J. Morris; George J. Bosl 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 100 KB 👁 2 views

Although the majority of patients with poor-risk germ-cell tumors (GCTs) will achieve a durable complete remission (CR) with standard first-line therapy, 20% to 30% of them will either relapse or fail to achieve an initial CR and eventually die. For this reason, the strategy of using high-dose (HD)